GIP and ovarian carcinoma: In this study, we generated a cell-penetrating interfering peptide GIP based on the F380/F382 residues, and confirmed its capacity to block the SPOCD1-AS/G3BP1 interaction, inhibit MMT features of mesothelial cells in vitro and suppressed ovarian cancer peritoneal metastasis in vivo.